Publication date: Jun 27, 2025
Autism Spectrum Disorder Clinical Trial Therapeutics 6. Autism Spectrum Disorder Pipeline Report Introduction 2. Autism Spectrum Disorder Pipeline Report Executive Summary 3. Key Products in the Autism Spectrum Disorder Pipeline 15. Autism Spectrum Disorder Pipeline Therapeutics Assessment 11. Inactive Products in the Autism Spectrum Disorder Pipeline 12. Autism Spectrum Disorder Pipeline: Late-Stage Products (Pre-registration) 7.
| Concepts | Keywords |
|---|---|
| Autism | Asd |
| Biotech | Autism |
| Driving | Clinical |
| Jazz | Disorder |
| June | Drugs |
| Inc | |
| Key | |
| Market | |
| Pharmaceuticals | |
| Phase | |
| Pipeline | |
| Spectrum | |
| Stage | |
| Therapeutics | |
| Therapies |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Autism Spectrum Disorder |
| drug | DRUGBANK | Alpha-Linolenic Acid |
| drug | DRUGBANK | Lumateperone |
| drug | DRUGBANK | Tromethamine |
| disease | MESH | ADHD |
| disease | MESH | Autism |
| drug | DRUGBANK | Medical Cannabis |
| disease | MESH | causes |
| disease | MESH | Aspergers Syndrome |
| disease | MESH | facial expressions |
| disease | MESH | echolalia |
Original Article
(Visited 2 times, 1 visits today)